Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (349)
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
2,778
Price
$117.55
Total Value
$326.55K
Shares Held After
0
% of Holdings
100.0%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP&Chief Mfg and Supply Cha
Shares
77
Price
$394.26
Total Value
$30.36K
Shares Held After
1,035
% of Holdings
6.9%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP&Chief Mfg and Supply Cha
Shares
77
Price
$394.00
Total Value
$30.34K
Shares Held After
1,112
% of Holdings
6.5%
CENTENE CORP (CNC)
KOSTER CHRISTOPHER — Secretary&General Counsel
Shares
47,603
Price
$65.36
Total Value
$3.11M
Shares Held After
305,354
% of Holdings
13.5%
Lexeo Therapeutics, Inc. (LXEO)
Otero Jose Manuel — Chief Operating Officer
Shares
1,304
Price
$4.96
Total Value
$6.46K
Shares Held After
136,178
% of Holdings
0.9%
Lexeo Therapeutics, Inc. (LXEO)
Townsend Richard Nolan — Director
Shares
3,345
Price
$4.95
Total Value
$16.56K
Shares Held After
374,472
% of Holdings
0.9%
Lexeo Therapeutics, Inc. (LXEO)
Tamayo Louis Edward — Chief Financial Officer
Shares
4,117
Price
$4.91
Total Value
$20.20K
Shares Held After
92,907
% of Holdings
4.2%
GLOBUS MEDICAL INC (GMED)
ZARRILLI STEPHEN T — Director
Shares
25,000
Price
$87.04
Total Value
$2.18M
Shares Held After
0
% of Holdings
100.0%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
31,031
Price
$20.05
Total Value
$622.32K
Shares Held After
39,900
% of Holdings
43.7%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
900
Price
$63.86
Total Value
$57.47K
Shares Held After
61,500
% of Holdings
1.4%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
4,100
Price
$63.27
Total Value
$259.39K
Shares Held After
62,400
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
441
Price
$518.65
Total Value
$228.72K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,630
Price
$518.19
Total Value
$844.64K
Shares Held After
324,884
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
873
Price
$517.09
Total Value
$451.42K
Shares Held After
326,514
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,880
Price
$516.04
Total Value
$970.16K
Shares Held After
327,387
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,333
Price
$514.99
Total Value
$1.20M
Shares Held After
329,267
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,264
Price
$514.18
Total Value
$649.92K
Shares Held After
331,600
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
439
Price
$513.06
Total Value
$225.23K
Shares Held After
332,864
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
170
Price
$511.59
Total Value
$86.97K
Shares Held After
333,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
231
Price
$510.47
Total Value
$117.92K
Shares Held After
333,473
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
239
Price
$509.48
Total Value
$121.77K
Shares Held After
333,704
% of Holdings
0.1%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Greenway Nicola Deidre Petal — Chief Human Resources Officer
Shares
12,980
Price
$18.11
Total Value
$235.12K
Shares Held After
40,049
% of Holdings
24.5%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP&Chairman, Partnering
Shares
100,000
Price
$59.97
Total Value
$6.00M
Shares Held After
370,401
% of Holdings
21.3%
UFP TECHNOLOGIES INC (UFPT)
Hudson Symeria — Director
Shares
298
Price
$319.11
Total Value
$95.09K
Shares Held After
927
% of Holdings
24.3%
MeiraGTx Holdings plc (MGTX)
Forbes Alexandria — Director
Shares
62,000
Price
$13.86
Total Value
$859.32K
Shares Held After
1,325,695
% of Holdings
4.5%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
31,801
Price
$37.18
Total Value
$1.18M
Shares Held After
18,630,739
% of Holdings
0.2%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
105,141
Price
$36.59
Total Value
$3.85M
Shares Held After
18,630,739
% of Holdings
0.6%
Invivyd, Inc. (IVVD)
Andersen Jill — Chief Legal Officer, Secretary
Shares
30,706
Price
$0.84
Total Value
$25.88K
Shares Held After
283,774
% of Holdings
9.8%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL&CORP SEC
Shares
145
Price
$32.47
Total Value
$4.71K
Shares Held After
21,225
% of Holdings
0.7%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL&CORP SEC
Shares
2,716
Price
$32.01
Total Value
$86.93K
Shares Held After
21,370
% of Holdings
11.3%
Invivyd, Inc. (IVVD)
Duke William E. — Chief Financial Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
168,937
% of Holdings
9.8%
Invivyd, Inc. (IVVD)
Lee Timothy Edward — Chief Commercial Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
178,937
% of Holdings
9.3%
Invivyd, Inc. (IVVD)
Allen Robert D. III — Chief Scientific Officer
Shares
17,043
Price
$0.84
Total Value
$14.37K
Shares Held After
178,765
% of Holdings
8.7%
Invivyd, Inc. (IVVD)
Green Julie — Chief Human Resources Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
168,937
% of Holdings
9.8%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
242
Price
$32.47
Total Value
$7.86K
Shares Held After
25,655
% of Holdings
0.9%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
4,525
Price
$32.01
Total Value
$144.83K
Shares Held After
25,897
% of Holdings
14.9%
Stoke Therapeutics, Inc. (STOK)
Kaye Edward M. MD — Director
Shares
637
Price
$32.47
Total Value
$20.68K
Shares Held After
124,557
% of Holdings
0.5%
Stoke Therapeutics, Inc. (STOK)
Kaye Edward M. MD — Director
Shares
11,930
Price
$32.01
Total Value
$381.85K
Shares Held After
125,194
% of Holdings
8.7%
STRYKER CORP (SYK)
King Debra — VP, Chief Digital and Information Officer
Shares
826
Price
$336.30
Total Value
$277.79K
Shares Held After
6,210
% of Holdings
11.7%
SHOULDER INNOVATIONS, INC. (SI)
Ahearn Matthew Fraser — Director
Shares
1,600
Price
$21.38
Total Value
$34.21K
Shares Held After
244,176
% of Holdings
0.7%
SHOULDER INNOVATIONS, INC. (SI)
Ahearn Matthew Fraser — Director
Shares
12,586
Price
$20.94
Total Value
$263.49K
Shares Held After
245,776
% of Holdings
4.9%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$75.82
Total Value
$265.37K
Shares Held After
153,902
% of Holdings
2.2%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
18,706
Price
$6.01
Total Value
$112.39K
Shares Held After
633,867
% of Holdings
2.9%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
16,696
Price
$6.01
Total Value
$100.31K
Shares Held After
565,592
% of Holdings
2.9%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
969
Price
$72.90
Total Value
$70.64K
Shares Held After
105,272
% of Holdings
0.9%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,844
Price
$72.39
Total Value
$133.49K
Shares Held After
106,241
% of Holdings
1.7%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP&Chief Mfg and Supply Cha
Shares
77
Price
$390.67
Total Value
$30.08K
Shares Held After
1,189
% of Holdings
6.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
4,730
Price
$26.18
Total Value
$123.83K
Shares Held After
36,475
% of Holdings
11.5%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,100
Price
$59.35
Total Value
$65.28K
Shares Held After
25,000
% of Holdings
4.2%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
3,900
Price
$58.37
Total Value
$227.65K
Shares Held After
26,100
% of Holdings
13.0%
Showing 1–50 of 349 transactions (page 1 of 7)